MACK DAVID J. — SEC Form 4 filings
SEC reporting owner CIK 1694466. 15 Form 4 filings on record with FilingPulse; latest filed 2026-01-12.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-11-25 to 2026-01-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | Director | 15 | — | — | 28 |
Form 4 filings — MACK DAVID J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-12 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Grant/award (A): 17,000 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,694 · Option exercise (M): 1,694 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,694 · Option exercise (M): 1,694 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,693 · Option exercise (M): 1,693 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,693 · Option exercise (M): 1,693 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,693 · Option exercise (M): 1,693 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,693 · Option exercise (M): 1,693 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,693 · Option exercise (M): 1,693 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,693 · Option exercise (M): 1,693 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 1,693 · Option exercise (M): 1,693 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 27,089 · Option exercise (M): 27,089 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 27,089 · Option exercise (M): 27,089 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4/A | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 27,089 · Option exercise (M): 27,089 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 27,089 · Grant/award (A): 297,988 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Grant/award (A): 325,077 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1694466 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →